Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation

Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation

Bibliographic Details
Main Authors:	N Waugh, E Cummins, P Royle, C Clar, M Marien, B Richter, S Philip
Format:	Article
Language:	English
Published:	NIHR Journals Library 2010-07-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta14360

Similar Items

Self-monitoring of blood glucose in type 2 diabetes: systematic review
by: C Clar, et al.
Published: (2010-03-01)

Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis.
by: Christine Clar, et al.
Published: (2009-07-01)

The clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluation
by: C Black, et al.
Published: (2007-09-01)

Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis
by: Sharma Pawana, et al.
Published: (2010-12-01)

Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation
by: Rhona Johnston, et al.
Published: (2017-01-01)

Risk of any hypoglycaemia with newer antihyperglycaemic agents in patients with type 2 diabetes: A systematic review and meta‐analysis
by: Sanaz Kamalinia, et al.
Published: (2020-01-01)

Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation
by: N Waugh, et al.
Published: (2013-11-01)

Liraglutide for the treatment of type 2 diabetes
by: D Shyangdan, et al.
Published: (2011-05-01)

Newer fungicidal agents
by: Walsh, Robert Augustine
Published: (2017)

Improving Uptake of Postnatal Checking of Blood Glucose in Women Who Had Gestational Diabetes Mellitus in Universal Healthcare Settings: A Systematic Review
by: Helen Sanderson, et al.
Published: (2018-12-01)

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation
by: E Cummins, et al.
Published: (2010-02-01)

Systematic reviews of epidemiology in diabetes: finding the evidence
by: Waugh Norman, et al.
Published: (2005-01-01)

Newer Chemortherapeutic Agents In Leprosy
by: Ganapati R, et al.
Published: (1996-01-01)

Newer agents in antiplatelet therapy: a review
by: Yeung J, et al.
Published: (2012-06-01)

Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review
by: Noyes Kathryn, et al.
Published: (2010-07-01)

Are the Newer Antidiabetic Agents Worth the Cost?
by: Sudhakar Pemminati, et al.
Published: (2016-03-01)

Newer agents for Helicobacter pylori eradication
by: Ricci C, et al.
Published: (2012-06-01)

Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation.
by: M Gillett, et al.
Published: (2012-08-01)

Gemigliptin: Newer promising gliptin for type 2 diabetes mellitus
by: Manish Gutch, et al.
Published: (2017-01-01)

Autologous chondrocyte implantation in the knee: systematic review and economic evaluation
by: Hema Mistry, et al.
Published: (2017-02-01)

The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review
by: M Connock, et al.
Published: (2006-03-01)

The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation
by: E Loveman, et al.
Published: (2003-08-01)

The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation
by: Loveman, E, et al.
Published: (2003)

Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation
by: C Clar, et al.
Published: (2005-12-01)

Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation
by: Y Dündar, et al.
Published: (2004-06-01)

Diabetic nephropathy: newer therapeutic perspectives
by: Krishna C. Keri, et al.
Published: (2018-07-01)

Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes
by: Áine M. de Bhailís, et al.
Published: (2021-05-01)

Self monitoring of blood glucose - a survey of Diabetes UK members with type 2 diabetes who use SMBG
by: Barnard, Katharine D., et al.
Published: (2010)

Self monitoring of blood glucose - a survey of diabetes UK members with type 2 diabetes who use SMBG
by: Young Amanda J, et al.
Published: (2010-11-01)

Newer anti-vascular endothelial growth factor agents
by: Priya Rasipuram Chandrasekaran
Published: (2020-01-01)

Newer Hemostatic Agents Used in the Practice of Dermatologic Surgery
by: Jill Henley, et al.
Published: (2013-01-01)

An update on newer pulpotomy agents in primary teeth: A literature review
by: Shruti Jha, et al.
Published: (2021-01-01)

Monitoring blood glucose control in diabetes mellitus: a systematic review.
by: Coster, et al.
Published: (2000-01-01)

Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis
by: Xiaofang Yu, et al.
Published: (2018-01-01)

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation
by: J Wilby, et al.
Published: (2005-04-01)

Insights into Newer Antimicrobial Agents against Gram-negative Bacteria
by: Neelam Yaneja, et al.
Published: (2016-01-01)

Insights into Newer Antimicrobial Agents Against Gram-negative Bacteria
by: Neelam Taneja, et al.
Published: (2016-03-01)

A Computational Approach towards the Development of Newer Anticancer Agents
by: Javed I. Sheikh, et al.
Published: (2010-01-01)

Blood glucose regulation in type II diabetic patients
by: Ekram, Fatemeh
Published: (2016)

Newer goals!!!
by: Balaji Manohar
Published: (2012-01-01)

Cannot write session to /tmp/vufind_sessions/sess_djadt8f9ojhquds6tv9k302qn5